Inhibition of circular JUN prevents the proliferation and invasion of glioblastoma via miR ‐3064‐ IGFBP5 axis
Journal of Cellular and Molecular Medicine · 2024
DOI: 10.1111/jcmm.70098 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Yuhao Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center, Department of Neurosurgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, …. Hauptthemen laut MEDLINE: MicroRNAs, Glioblastoma, Cell Proliferation, RNA, Circular. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Glioblastoma (GBM) remains one of the most aggressive and lethal brain tumours, characterized by rapid progression and limited treatment options. This study investigated the regulatory roles of circular RNA circJUN, and its functional interaction with microRNA miR‐3064 in GBM pathogenesis. We employed bioinformatic analyses and clinical sample validation to identify circJUN as a potential target in GBM. Subsequently, we engineered GBM cell lines with stable circJUN knockout or overexpression, and transfected them with miR‐3064 mimic/inhibitor or IGFBP5 small interfering RNA (siRNA)/expression vector to elucidate the molecular mechanisms governing GBM proliferation and invasion. To investigate the in vivo effects, xenograft tumour models were established in nude mice using engineered cells to assess the roles of circJUN in tumour growth regulation. Our analyses revealed significant overexpression of circJUN in GBM tissues compared to healthy controls, which strongly correlated with poor patient prognosis. In vitro and in vivo experiments demonstrated that circJUN overexpression could enhance GBM cell proliferation and invasion. Mechanistic investigations uncovered EIF4A3 as an interacting factor of circJUN which promotes circJUN expression, and circJUN modulates miR‐3064 activity to regulate the malignancy of GBM cells. Furthermore, we identified IGFBP5, a crucial regulator of cell growth, as a direct target of miR‐3064, thereby establishing an additional layer of control over GBM proliferation and invasion. Our study unveils a complex regulatory network involving circJUN, miR‐3064 and IGFBP5 in GBM pathogenesis, underscoring their potential as novel therapeutic targets for improving patient outcomes. Our findings not only contribute to the understanding of GBM biology but also pave the way for innovative therapeutic approaches in the management of this malignancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Center, Department of Neurosurgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China.
- General Surgery, Cancer Center, Department of Gastrointestinal and Pancreatic Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China.
ORCID-Profile: Faliang Gao
Förderung
- China Postdoctoral Science Foundation
Zitieren
APA
Zhang, Y., Liu, S., Wu, C., Gao, X., Zhao, H., Li, O., & Gao, F. (2024). Inhibition of circular JUN prevents the proliferation and invasion of glioblastoma via miR ‐3064‐ IGFBP5 axis. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70098
Vancouver
Zhang Y, Liu S, Wu C, Gao X, Zhao H, Li O, et al. Inhibition of circular JUN prevents the proliferation and invasion of glioblastoma via miR ‐3064‐ IGFBP5 axis. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.70098
BibTeX
@article{Zhang2024,
author = {Zhang, Yuhao and Liu, Shiming and Wu, Cheng and Gao, Xin and Zhao, Hongtao and Li, Ou and Gao, Faliang},
title = {Inhibition of circular JUN prevents the proliferation and invasion of glioblastoma via miR ‐3064‐ IGFBP5 axis},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
doi = {10.1111/jcmm.70098}
}
EUVIMED